Yuksek Ihtisas University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Ankara Turkey (2013)

Organization Overview

First Clinical Trial
2013
NCT01451320
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bursa Yuksek ihtisas research and training hospital | Kartal Kosuyolu High Speciality Training and Research H | Kartal Kosuyolu High Speciality Training and Research Hospital | Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital | Turkey Yuksek Ihtisas Education and Research Hospital | Turkiye Yuksek Ihtisas Education and Research Hospital | University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital | Yuksek Ihtisas Hospital | Yuksek Ihtisas University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 3)

Cardiomyopathies (Phase 2)

Coronary Artery Disease (Phase 4)

Drug Overdose (Phase 4)

Hemorrhage (Phase 4)

Infarction (Phase 2)

Mitral Valve Stenosis (Phase 4)

Myocardial Infarction (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 18
  • # of Trial APIs: 22